As shown in Table 2, more of gastric cancer patients expressing IGF-IR were at late-stage pTNM (p < 0.001) and examined with lymph node metastasis (p < 0.001). This evidence concerns the gene IGF1R and metastatic malignant neoplasm in the lymph nodes.